After losing and regaining the same 20-plus pounds more times than she could count, Anita Blanchard concluded that diets ...
More than 7 million Americans struggling with obesity would become eligible for coverage under the proposed change ...
The Centers for Medicare and Medicaid Services proposed changes to reduce prescription drug costs for Medicare Advantage and ...
It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...
CHARLESTON — West Virginia Gov. and Senator-elect Jim Justice said Tuesday he supports a plan by President Joe Biden’s ...
Under Secretary for Health Dr. Shereef Elnahal said Monday the VA needs extra funding to cover the costs of drugs such as ...
The Biden administration announced Tuesday it’s reinterpreting federal law to allow Medicare and Medicaid patients access to anti-obesity medications to reduce their weight over the long term.
A new HHS rule would require Medicare and Medicaid to cover drugs like Wegovy or Zepbound for a large segment of Americans.
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...
The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and ...
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...
It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.